NOTV241220P10000
- 0.00
- 0.000.00%
Inotiv Newsroom
Insider Purchase: Director at $NOTV (NOTV) Buys 10,000 Shares
Inotiv Insider Bought Shares Worth $414,000, According to a Recent SEC Filing
Lake Street Maintains Inotiv(NOTV.US) With Buy Rating, Maintains Target Price $6
Analysts Offer Insights on Healthcare Companies: Inotiv (NOTV), Ascendis Pharma (ASND) and Champions Oncology (CSBR)
Inotiv, Inc. Faces Financial Turmoil: Going Concern Doubts and Debt Pressures
Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating, Announces Target Price $10
Lake Street Maintains Inotiv(NOTV.US) With Buy Rating, Raises Target Price to $6
Inotiv | 10-K: FY2024 Annual Report
Inotiv, Inc. (NOTV) Q4 2024 Earnings Call Transcript Summary
Express News | Inotiv Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q4 Financial Results
Inotiv | 8-K: Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update
Inotiv 4Q Loss/Shr 73c >NOTV
Earnings Flash (NOTV) INOTIV Posts Q4 Revenue $130.4M, Vs. Street Est of $116.9M
Express News | Inotiv FY 2024 Adj. EPS $(4.19) Beats $(4.43) Estimate, Sales $490.700M Beat $477.248M Estimate
Express News | Inotiv Q4 Operating Income USD -13.2 Million
Earnings Scheduled For December 3, 2024
Uncovering Potential: Inotiv's Earnings Preview
Inotiv Management to Meet Virtually With Lake Street
Earnings Preview: Inotiv to Report Financial Results Post-market on December 03
Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500